| Adjusted indices of multiple deprivation to enable comparisons within and between constituent countries of the UK including an illustration using mortality rates GA Abel, ME Barclay, RA Payne BMJ open 6 (11), e012750, 2016 | 255 | 2016 |
| The problem with composite indicators M Barclay, M Dixon-Woods, G Lyratzopoulos BMJ quality & safety 28 (4), 338-344, 2019 | 171 | 2019 |
| Empathy among undergraduate medical students: A multi-centre cross-sectional comparison of students beginning and approaching the end of their course TA Quince, P Kinnersley, J Hales, A da Silva, H Moriarty, P Thiemann, ... BMC medical education 16 (1), 92, 2016 | 169 | 2016 |
| Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer … S McPhail, R Swann, SA Johnson, ME Barclay, H Abd Elkader, R Alvi, ... The lancet oncology 23 (5), 587-600, 2022 | 137 | 2022 |
| Cancer-related fatigue in adolescents and young adults after cancer treatment: persistent and poorly managed A Spathis, H Hatcher, S Booth, F Gibson, P Stone, L Abbas, M Barclay, ... Journal of adolescent and young adult oncology 6 (3), 489-493, 2017 | 66 | 2017 |
| The outcome of patients with surgically treated meningioma in England: 1999–2013. A cancer registry data analysis AR Brodbelt, ME Barclay, D Greenberg, M Williams, MD Jenkinson, ... British journal of neurosurgery 33 (6), 641-647, 2019 | 50 | 2019 |
| Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study ME Barclay, G Lyratzopoulos, FM Walter, S Jefferies, MD Peake, ... Thorax 74 (5), 466-472, 2019 | 47 | 2019 |
| Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its … ME Barclay, GA Abel, DC Greenberg, B Rous, G Lyratzopoulos British journal of cancer 124 (7), 1320-1329, 2021 | 46 | 2021 |
| Preferences for care towards the end of life when decision-making capacity may be impaired: A large scale cross-sectional survey of public attitudes in Great Britain and the … G Clarke, E Fistein, A Holland, M Barclay, P Theimann, S Barclay Plos one 12 (4), e0172104, 2017 | 37 | 2017 |
| Stage-specific incidence trends of melanoma in an English region, 1996–2015: longitudinal analyses of population-based data A Herbert, MM Koo, ME Barclay, DC Greenberg, GA Abel, NJ Levell, ... Melanoma research 30 (3), 279-285, 2020 | 35 | 2020 |
| Effect of a skin self-monitoring smartphone application on time to physician consultation among patients with possible melanoma: a phase 2 randomized clinical trial FM Walter, MM Pannebakker, ME Barclay, K Mills, CL Saunders, ... JAMA network open 3 (2), e200001-e200001, 2020 | 31 | 2020 |
| A'telephone first'approach to demand management in English general practice: a multimethod evaluation J Newbould, S Ball, G Abel, M Barclay, T Brown, J Corbett, B Doble, ... Health and Social Care Delivery Research 7 (17), 1-158, 2019 | 29 | 2019 |
| Factors affecting short-term mortality in women with ovarian, tubal, or primary peritoneal cancer: population-based cohort analysis of English National Cancer Registration Data M Barclay, C Gildea, J Poole, L Hirschowitz, U Menon, A Nordin International Journal of Gynecological Cancer 26 (1), 56-65, 2016 | 25 | 2016 |
| Missing data and chance variation in public reporting of cancer stage at diagnosis: cross-sectional analysis of population-based data in England ME Barclay, G Lyratzopoulos, DC Greenberg, GA Abel Cancer epidemiology 52, 28-42, 2018 | 24 | 2018 |
| Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP … S McPhail, ME Barclay, SA Johnson, R Swann, R Alvi, A Barisic, O Bucher, ... The Lancet Oncology 25 (3), 338-351, 2024 | 20 | 2024 |
| Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000–2010 RCJ Hsu, M Barclay, MA Loughran, G Lyratzopoulos, VJ Gnanapragasam, ... Bju International 122 (4), 599-609, 2018 | 19 | 2018 |
| The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit N Zakkak, ME Barclay, R Swann, S McPhail, G Rubin, GA Abel, ... British Journal of Cancer 130 (2), 297-307, 2024 | 18 | 2024 |
| “What’s the evidence?”—Towards more empirical evaluations of the impact of OR interventions in healthcare G Lamé, S Crowe, M Barclay Health Systems 11 (1), 59-67, 2022 | 18 | 2022 |
| Impact of loss-to-follow-up on cancer survival estimates for small populations: a simulation study using Hospital-Based Cancer Registries in Japan A Okuyama, M Barclay, C Chen, T Higashi BMJ open 10 (1), e033510, 2020 | 17 | 2020 |
| Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP … S McPhail, ME Barclay, R Swann, SA Johnson, R Alvi, A Barisic, O Bucher, ... The Lancet Oncology 25 (3), 352-365, 2024 | 15 | 2024 |
Georgios LyratzopoulosProfessor of Cancer Epidemiology, Epidemiology of Cancer Healthcare & Outcomes (ECHO), UCLVerified email at ucl.ac.uk
